Canopy
Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in
cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE:
TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant
expansion at its Mississauga, Ontario facility. TerrAscend anticipates that the
approval will assist in the company’s goal to meet the growing consumer demand
for premium cannabis products and brands expected to surge as the next wave of
Canadian cannabis legalization. The approval almost triples TerrAscend’s licensed
space to 51,800 square feet. The new space will be comprised of supplementary
cultivation capacity, a commercial kitchen, formulation rooms and larger
primary and secondary packaging capacity.
To view the full press release, visit http://ibn.fm/Jfqxw
About Canopy Rivers Inc.
Canopy Rivers is a venture capital firm specializing in
cannabis. Its unique investment and operating platform is structured to pursue
investment opportunities in the emerging global cannabis sector. Canopy Rivers
identifies strategic counterparties seeking financial and/or operating support.
Canopy Rivers has developed an investment ecosystem of complementary cannabis
operating companies that represent various segments of the value chain across
the emerging cannabis sector. As the portfolio continues to develop,
constituents will be provided with opportunities to work with Canopy Growth
Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which
Canopy Rivers believes will maximize value for its shareholders and foster an
environment of innovation, synergy and value creation for the entire ecosystem.
For more information, visit the company’s website at www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates
relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news breaks
keep you up-to-date with the day’s top movers. MissionIR is primarily focused
on strategic communications. We have executed countless communications programs
to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
